Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving nucleotides. [GOC:go_curators]
Negative regulation of nucleotide metabolic process involves a complex interplay of molecular mechanisms that modulate the rate and direction of nucleotide synthesis, degradation, and utilization. This regulation is crucial for maintaining cellular homeostasis, ensuring proper DNA replication and repair, and supporting diverse cellular functions.
**Key Regulatory Mechanisms:**
* **Transcriptional Regulation:** Gene expression of enzymes involved in nucleotide metabolism can be regulated at the transcriptional level. Transcription factors, often influenced by cellular signals like nutrient availability and growth factors, can bind to promoter regions of nucleotide metabolic genes, either activating or repressing their expression.
* **Post-Translational Modification:** Enzymes involved in nucleotide metabolism can be subject to post-translational modifications, such as phosphorylation, acetylation, and ubiquitination. These modifications can alter enzyme activity, stability, and localization, ultimately affecting nucleotide metabolism.
* **Allosteric Regulation:** Feedback loops can regulate nucleotide metabolism. Products of nucleotide metabolism can bind to and inhibit the activity of enzymes involved in their own synthesis, preventing overproduction. This feedback inhibition helps maintain nucleotide pools within a narrow physiological range.
* **Metabolic Flux Control:** Cellular energy status and demand for nucleotides can influence the direction of metabolic fluxes through different pathways. For example, under high energy demand, the cell may prioritize ATP production, leading to increased nucleotide synthesis and degradation pathways.
* **Cellular Signaling Pathways:** Various signaling pathways, such as the PI3K-Akt pathway and the mTOR pathway, play a role in regulating nucleotide metabolism. These pathways can be activated by growth factors, nutrient availability, and other stimuli, influencing the expression and activity of enzymes involved in nucleotide metabolism.
**Biological Significance:**
* **DNA Replication and Repair:** Proper regulation of nucleotide metabolism is essential for DNA replication and repair. A balanced supply of nucleotides is crucial for the accurate and efficient replication of the genome.
* **Cell Growth and Proliferation:** Nucleotides are essential building blocks for DNA and RNA, and their availability influences cell growth and proliferation. Regulation of nucleotide metabolism ensures that the cell has adequate supplies for these processes.
* **Cellular Signaling and Differentiation:** Nucleotides are involved in a wide range of cellular signaling pathways, and their availability can influence cell fate decisions, such as differentiation and apoptosis.
* **Immune Response:** Nucleotides are involved in the regulation of the immune response, including the production of cytokines and other immune mediators.
**Dysregulation of Negative Regulation of Nucleotide Metabolic Process:**
Dysregulation of negative regulation of nucleotide metabolic processes can lead to a variety of cellular abnormalities and diseases, including:
* **Cancer:** Increased nucleotide metabolism is often observed in cancer cells, fueling their uncontrolled growth and proliferation.
* **Genetic Disorders:** Mutations in genes involved in nucleotide metabolism can lead to genetic disorders such as Lesch-Nyhan syndrome and adenosine deaminase deficiency.
* **Neurological Disorders:** Dysregulation of nucleotide metabolism has been implicated in neurological disorders such as Parkinson's disease and Alzheimer's disease.
**Conclusion:**
Negative regulation of nucleotide metabolic process is a fundamental cellular process that maintains cellular homeostasis and supports diverse cellular functions. This intricate regulatory network ensures the precise balance of nucleotide synthesis, degradation, and utilization, safeguarding cellular integrity and promoting healthy cell function.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cytidine deaminase | A cytidine deaminase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P32320] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
uridine | uridines | drug metabolite; fundamental metabolite; human metabolite | |
cytidine | cytidines | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | |
cytarabine | beta-D-arabinoside; monosaccharide derivative; pyrimidine nucleoside | antimetabolite; antineoplastic agent; antiviral agent; immunosuppressive agent | |
deoxycytidine | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | |
gemcitabine | gemcitabine : A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. | organofluorine compound; pyrimidine 2'-deoxyribonucleoside | antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic |
5,6-dihydrouridine | dihydrouridine : The uridine derivative obtained by formal hydrogenation of the endocyclic double bond in the uracil ring. | uridines | biomarker |
pyrimidin-2-one beta-ribofuranoside | pyrimidin-2-one beta-ribofuranoside: RN given refers to (D)-isomer; structure | pyrimidine ribonucleosides | |
2'-fluoro-2'-deoxycytidine | |||
2'-c-methylcytidine | 2'-C-methylcytidine: structure in first source | ||
psi 6130 | 2'-deoxy-2'-fluoro-2'-C-methylcytidine: PSI-6130 is the (beta-D)-isomer; has antiviral activity against hepatitis C virus; structure in first source |